I don't think ATH is involved in any FA trial at the moment. Chances are Ashley Pall got interested in the research. She still appears as a PhD student on the Wayne State University website. It appears we have many collaborators and the wonder molecule continues to gain traction in the neurodegenerative disorder space. It's gonna be interesting to know what her findings are. Good news.
Ann: Alterity to Present New ATH434 Data at Orphan Drug Congress, page-18
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.001(11.1%) |
Mkt cap ! $23.94M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $1.288K | 257.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 103 | 97718686 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 31179254 | 15 |
View Market Depth
| Last trade - 09.59am 26/07/2024 (20 minute delay) ? |
| ATH (ASX) Chart |